No info available.

• Member, Brazilian Academy of Sciences - Brazilian Academy of Sciences (12/01/2022)
• Guest Editor, PLOS Pathogens - PLOS Pathogens (06/01/2020-06/30/2020)
• Ad-hoc member, Special Emphasis Panel/Scientific Review Group 2020/05 ZTR1 NTU-2 (01) 1 - NIH (02/01/2020-02/28/2020)
• Editorial Board, Microorganisms - Molecular Diversity Preservation Internationa (MDPI) (11/01/2019-11/30/2019)
• Science and Technology Acquisition and Retention Program (STARs) Award, US$500,000 - The University of Texas System (03/01/2019-03/31/2019)
• Associate Editor, PLOS Neglected Tropical Diseases - PLOS Neglected Tropical Diseases (03/01/2019)
• Fellow-Elected, American Academy of Microbiology (AAM) - American Academy of Microbiology (AAM) (03/01/2017)
• Member of Special Emphasis Panel/Scientific Review Group 2016/05 ZAI1 PA-I (M2) - National Institutes of Health (NIH)/ NAID (01/01/2015-12/31/2015)
• Member of the Editorial Board - Parasitology International (01/01/2015-12/31/2015)
• Member of the Editorial Board (Review Editor) - Frontiers in Mycology (01/01/2015-12/31/2015)
• Outstanding Performance Award for Securing Extramural Funding - Office of Research and Sponsored Projects (ORSP), College of Science (COS), UTEP (01/01/2015-12/31/2015)
• Special Visiting Researcher - Science Without Borders Program, Brazilian National Research Council (CNPq) (01/01/2015-12/31/2015)
• Member of the Editorial Board - Journal of Glycomics & Lipidomics (01/01/2014-12/31/2014)
• Member of the Editorial Board - Parasitology International (01/01/2014-12/31/2014)
• Member of the Editorial Board (Review Editor) - Frontiers in Mycology (01/01/2014-12/31/2014)
• Special Visiting Researcher - Science Without Borders Program, Brazilian National Research Council (CNPq) (01/01/2014-12/31/2014)
• Member of the Editorial Board - Journal of Glycomics & Lipidomics (01/01/2013-12/31/2013)
• Member of the Editorial Board - Parasitology International (01/01/2013-12/31/2013)
• Member of the Editorial Board (Review Editor) - Frontiers in Mycology (01/01/2013-12/31/2013)
• Special Visiting Researcher - Science Without Borders Program, Brazilian National Research Council (CNPq) (01/01/2013-12/31/2013)
• NIH Peer Review Committee Member - NIH/Pathogenic Eukaryotes Review Panel (PTHE) (06/01/2013-06/30/2013)
• Distinguished Achievement Award for Research - University of Texas at El Paso (05/01/2013-05/31/2013)
• Research Accomplishment Award - College of Science, University of Texas at El Paso (05/01/2013-05/31/2013)
• Member of the Editorial Board - Parasitology International (01/01/2012-12/31/2012)
• Member of the Editorial Board (Review Editor) - Frontiers in Mycology (01/01/2012-12/31/2012)
• Special Visiting Researcher - Science Without Borders Program, Brazilian National Research Council (CNPq) (01/01/2012-12/31/2012)
• Millionaire Research Award - Office of Research and Sponsored Projects (ORSP), University of Texas at El Paso (UTEP) (04/01/2012-04/30/2012)
• Member of the Editorial Board - Journal of Glycomics & Lipidomics (01/01/2011-12/31/2011)
• Member of the Editorial Board (Review Editor) - Frontiers in Mycology (01/01/2011-12/31/2011)
• Regular Member of Pathogenic Eukaryotes (PTHE) Review Panel - National Institutes of Health (NIH) (01/01/2011-12/31/2011)
• Outstanding Performance Award for Securing Extramural Funding - Office of Research and Projects (ORSP), College of Science (COS), UTEP (05/01/2011-05/31/2011)
• Outstanding Performance Award for Securing Extramural Funding - Office of Research and Projects (ORSP), College of Science (COS), UTEP (05/01/2011-05/31/2011)
• Outstanding Performance Award for Securing Extramural Funding - Office of Research and Projects (ORSP), College of Science (COS), UTEP (05/01/2011-05/31/2011)
• Member of the Editorial Board - Parasitology International (12/01/2010)
• Member of the Editorial Board (Review Editor) - Frontiers in Mycology (12/01/2010)
• Member of the Editorial Board - Journal of Glycomics & Lipidomics (11/01/2010)
• Distingued Achievement Award - College of Science, UTEP (05/08/2009)
• STARS Block Award - (UT System funds), University of Texas at El Paso, College of Science (07/01/2007-07/31/2007)
• Proteomics and Bioinformatics Workshop Team Travel Award (01/31/2006)

• Microbiology, University of Dundee (1998)
• Ph D in Microbiology and Immunology, Escola Paulista de Medicina-EPM (currently UNIFESP) (1994)
• MS in Molecular Biology, Escola Paulista de Medicina (EPM),Federal University of Sao Paulo (UNIFESP) (1989)
• Pharmacy degree, Universidade Regional do Nordeste (currently UEPb) (1981)

• Big is not better: Comparing two alpha-Gal-bearing glycotopes in neoglycoproteins as biomarkers for Leishmania (Viannia) braziliensis infection Carbohydrate research Carbohydrate Research: 536 (2023), Alberto Montoya, E R. Gil, I Vinales, I L. Estevao, P Taboada, M C. Torrico, F Torrico, J D. Marco, Igor C. Almeida, Katja Michael.
• Oncogenic KRASG12D Reprograms Lipid Metabolism by Upregulating SLC25A1 to Drive Pancreatic Tumorigenesis. Cancer Research Cancer Research 83 22 (2023), R Zhang, X Peng, J X. Du , R Boohaker, I L. Estevao, B I. Grajeda, Marc B. Cox, Igor C. Almeida, Weiqin Lu.
• Traversing the Cell Wall: The Chitinolytic Activity of Histoplasma capsulatum Extracellular Vesicles Facilitates Their Release. Journal of Fungi (Basel, Switzerland) Journal of Fungi (Basel, Switzerland) 9 11 (2023), Alessandro Valdez, T N. de Souza, Bonilla JJA, D Zamith-Miranda, A C. Piffer, Araujo GRS, A J. Guimarães, S Frases, A K. Pereira, T P. Fill, I L. Estevao, Alejandro Torres, Igor C. Almeida, J D. Nosanchuk, L Nimrichter.
• Fatty acid elongases 1-3 have distinct roles in mitochondrial function, growth, and lipid homeostasis in Trypanosoma cruzi. The Journal of Biological Chemistry The Journal of Biological Chemistry 299 6 (2023), L Pagura, P C. Dumoulin, Carla Ellis, M T. Mendes, I L. Estevao, Igor C. Almeida, B A. Burleigh.
• The Trypanosoma brucei MISP family of invariant proteins is co-expressed with BARP as triple helical bundle structures on the surface of salivary gland forms, but is dispensable for parasite development within the tsetse vector. PLoS Pathogens PLoS Pathogens 19 3 (2023), A Casas-Sanchez, R Ramaswamy, S Perally, L R. Haines, C Rose, M Aguilera-Flores, S Portillo, M Verbeelen, S Hussain, L Smithson, C Yunta, M J. Lehane, S Vaughan, J van den Abbeele, Igor C. Almeida, M J. Boulanger, Á Acosta-Serrano.
• Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy. PLoS neglected tropical diseases 17 3 (2023), P Silva Grijó Farani, B da Iandra Silva Ferreira, K Begum, G Vilar-Pereira, I R. Pereira, E A. Fernández-Figueroa, R A. Cardenas-Ovando, Igor C. Almeida, Sourav Roy, J Lannes-Vieira, O C. Moreira.
• Synthesis and Photoreactivity of 7-Nitroindoline-S-thiocarbamates ACS Omega 8 (2023), Philip T. Baily, H. P. Del Castillo, Irodiel Vinales, Juan E. Urbay, Aurelio Paez, Matthew R. Weaver, Roberto Iturralde, Igor L. Estevao, Sohan R. Jankuru, Igor C. Almeida, Chunquiang Li, Carl W. Dirk, Katja Michael.
• Oncogenic KRASG12D reprograms lipid metabolism by upregulating SLC25A1 to drive pancreatic tumorigenesis Cancer Research 83 22 (2023), R. Zhang, X. Peng, J.X. Du, R. Boohaker, I. Estevao, B. Grajeda, Marc B. Cox, Igor C. Almeida, Weiqin Lu.
• Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins. Emerging Microbes & Infections Emerging Microbes & Infections 11 1 (2022), S M. Viana, Alberto Montoya, A M. Carvalho, B S. de Mendonça, S Portillo, J J. Olivas, N H. Karimi, I L. Estevao, U Ortega-Rodriguez, E M. Carvalho, W O. Dutra, R A. Maldonaldo, Katja Michael, C I. de Oliveira, Igor C. Almeida.
• Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins. Emerging microbes & infections 11 1 (2022), S M. Viana, Alberto Montoya, A M. Carvalho, B S. de Mendonça, S Portillo, J J. Olivas, N H. Karimi, I L. Estevao, U Ortega-Rodriguez, E M. Carvalho, W O. Dutra, R A. Maldonaldo, Katja Michael, C I. de Oliveira, Igor C. Almeida.
• A Branched and Double Alpha-Gal-Bearing Synthetic Neoglycoprotein as a Biomarker for Chagas Disease. Molecules (Basel, Switzerland) Molecules (Basel, Switzerland) 27 17 (2022), Alberto Montoya, E G. Carvajal, U Ortega-Rodriguez, I L. Estevao, R A. Ashmus, S R. Jankuru, S Portillo, Carla Ellis, C D. Knight, J Alonso-Padilla, L Izquierdo, M J. Pinazo, J Gascon, V Suarez, Douglas Watts, I R. Malo, J M. Ramsey, B De Alarcón Noya, O Noya, Igor C. Almeida, Katja Michael.
• A branched, double alpha-Gal-bearing synthetic neoglycoprotein as a biomarker for Chagas disease Molecules 27 (2022), Alba L. Montoya, Elisa G. Carvajal, Uriel Ortega-Rodriguez, Igor L. Estevao, Roger A. Ashmus, Sohan R. Jankuru, Susana Portillo, Cameron C. Ellis, Colin D. Knight, Julio Alonso-Padilla, Luis Izquierdo, Maria-Jesus Pinazo, Joaquim Gascon, Veronica Suarez, Douglas M. Watts, Iliana R. Malo, Janine M. Ramsey, Belkisyolé Alarcón De Noya, Oscar Noya, Igor C. Almeida, Katja Michael.
• Giardial lipid rafts share virulence factors with secreted vesicles and participate in parasitic infection in mice. Frontiers in Cellular and Infection Microbiology Frontiers in Cellular and Infection Microbiology 12 (2022), B I. Grajeda, A De Chatterjee, C M. Villalobos, B C. Pence, Carla Ellis, V Enriquez, Sourav Roy, Sukla Roychowdhury, A K. Neumann, Igor C. Almeida, Samantha Patterson, Siddhartha Das.
• Extracellular Vesicles Regulate Biofilm Formation and Yeast-to-Hypha Differentiation in Candida albicans. mBio 13 3 (2022), L Honorato, de Araujo JFD, Carla Ellis, A C. Piffer, Y Pereira, S Frases, G R. de Sousa Araújo, B Pontes, M T. Mendes, M D. Pereira, A J. Guimarães, N M. da Silva, G Vargas, L Joffe, M Del Poeta, J D. Nosanchuk, D Zamith-Miranda, Dos Reis FCG, H C. de Oliveira, M L. Rodrigues, S de Toledo Martins, L R. Alves, Igor C. Almeida, L Nimrichter.
• Inhibition of Protein N-Glycosylation Blocks SARS-CoV-2 Infection mBio (2022), A Casas-Sanchez, A Romero-Ramirez, E Hargreaves, Carla Ellis, B I. Grajeda, I L. Estevao, E I. Patterson, G L. Hughes, Igor C. Almeida, T Zech, Á Acosta-Serrano.
• Sheltered in Stromal Tissue Cells, <i>Trypanosoma cruzi</i> Orchestrates Inflammatory Neovascularization via Activation of the Mast Cell Chymase Pathway Pathogens (Basel, Switzerland) Pathogens (Basel, Switzerland) 11 2 (2022), L Vellasco, E Svensjö, C A. Bulant, P J. Blanco, F Nogueira, G Domont, N P. de Almeida, C R. Nascimento, D Silva-Dos-Santos, C E. Carvalho-Pinto, E H. Medei, Igor C. Almeida, J Scharfstein.
• Specific Recognition of β-Galactofuranose-Containing Glycans of Synthetic Neoglycoproteins by Sera of Chronic Chagas Disease Patients. Molecules (Basel, Switzerland) Molecules (Basel, Switzerland) 27 2 (2022), Alba L. Montoya, Eileni R. Gil, E L. Heydemann, Igor L. Estevao, Bianca E. Luna, Cameron C. Ellis, Sohan R. Jankuru, Belkisyolé Alarcón de Noya, Oscar Noya, Maria P. Zago, Igor C. Almeida, Katja Michael.
• Specific Recognition of β-Galactofuranose-Containing Glycans of Synthetic Neoglycoproteins by Sera of Chronic Chagas Disease Patients Molecules 27 (2022), Alba L. Montoya, Eileni R. Gil, Emily L. Heydemann, Igor L. Estevao, Bianca E. Luna, Cameron C. Ellis, Sohan R. Jankuru, Belkisyole Alarcon de Noya, Oscar Noya, Maria P. Zago, Igor C. Almeida, Katja Michael.
• Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins Emerging Microbes & Infections 11 1 (2022), Sayonara Viana, Alba L. Montoya, Augusto M. Carvalho, Brunele S. de Mendonca, Susana Portillo, Janet J. Olivas, Nassim H. Karimi, Igor L. Estevao, Uriel Ortega-Rodriguez, Edgar M. Carvalho, Walderez O. Dutra, Rosa A. Maldonado, Katja Michael, , Camila I. de Oliveira, Igor C. Almeida.
• New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia. BMJ Open BMJ Open 11 12 (2021), Cristina Alonso-Vega, Julio A. Urbina, Sergi Sanz, María-Jesús Pinazo, Jimy J. Pinto, Virginia R. Gonzalez, Gimena Rojas, Lourdes Ortiz, Wilsoon Garcia, Daniel Lozano, Dolors Soy, Rosa A. Maldonado-Medina, Rana Nagarkatti, Alain Debrabant, Alejandro Schijman, Maria C. Thomas, Manuel C. López, Katja Michael, Isabela Ribeiro, Joaquim Gascon, Faustino Torrico, Igor C. Almeida.
• New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial. The Lancet Infectious Diseases The Lancet Infectious Diseases 21 8 (2021), F Torrico, J Gascón, F Barreira, B Blum, Igor C. Almeida, C Alonso-Vega, T Barboza, G Bilbe, E Correia, W Garcia, L Ortiz, R Parrado, J C. Ramirez, I Ribeiro, N Strub-Wourgaft, M Vaillant, S Sosa-Estani.
• Treatment with Suboptimal dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice with Chronic Chagasic Cardiomyopathy Front Cell Infect Microbiol 11 (2021), Priscila S. Grijó Farani, Khodeza Begum, Glaucia Vilar-Pereira, Isabela R. Pereira , Igor C. Almeida, Sourav Roy, Joseli Lannes-Vieira, Otacilio C. Moreira.
• Reversed Immunoglycomics Identifies α-Galactosyl-Bearing Glycotopes Specific for <i>Leishmania major</i> Infection JACS Au JACS Au 1 8 (2021), Alberto Montoya, V M. Austin, S Portillo, I Vinales, R A. Ashmus, I Estevao, S R. Jankuru, Y Alraey, W S. Al-Salem, Á Acosta-Serrano, Igor C. Almeida, Katja Michael.
• Omics Approaches for Understanding Biogenesis, Composition and Functions of Fungal Extracellular Vesicles. Frontiers in Genetics 12 (2021), D Zamith-Miranda, R da Peres Silva, S P. Couvillion, E L. Bredeweg, M C. Burnet, C Coelho, Elizabeth Camacho, L Nimrichter, R Puccia, Igor C. Almeida, A Casadevall, M L. Rodrigues, L R. Alves, J D. Nosanchuk, E S. Nakayasu.
• Glycoconjugates and methods for their use U.S. Patent (2021), Igor C. Almeida, Katja Michael, Nate Schocker, Susana Portillo, Rosa A. Maldonado.
• New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia BMJ Open 11 (2021), C Alonso-Vega, Julio A. Urbina, S Saenz, Maria J. Espinazo, j J. Pinto, V R. Gonzalez, G Rojas , L Ortiz, W Garcia, D Lozano, D Soy, Rosa A. Maldonado-Medina, R Nagarkatti, A Debrabant, Alejandro Schijman,, Maria C. Thomas, Manuel C. Lopez, Katja Micheal, Isabel Ribeiro, J Gascon, Faustino Torrico, Igor C. Almeida.
• Plasma-Derived Extracellular Vesicles as Potential Biomarkers in Heart Transplant Patient with Chronic Chagas Disease. Emerging infectious diseases 26 8 (2020), N Cortes-Serra, M T. Mendes, C Mazagatos, J Segui-Barber, Cameron C. Ellis, C Ballart, A Garcia-Alvarez, M Gállego, J Gascon, Igor C. Almeida, M J. Pinazo, C Fernandez-Becerra.
• Plasma-derived extracellular vesicles from Plasmodium vivax patients signal spleen fibroblasts via NF-kB facilitating parasite cytoadherence. Nature communications 11 1 (2020), H Toda, M Diaz-Varela, J Segui-Barber, W Roobsoong, B Baro, S Garcia-Silva, A Galiano, M Gualdrón-López, Almeida ACG, Brito MAM, G C. de Melo, I Aparici-Herraiz, C Castro-Cavadía, W M. Monteiro, E Borràs, E Sabidó, Igor C. Almeida, J Chojnacki, J Martinez-Picado, M Calvo, P Armengol, J Carmona-Fonseca, M F. Yasnot, R Lauzurica, A Marcilla, H Peinado, M R. Galinski, Lacerda MVG, J Sattabongkot, C Fernandez-Becerra, H A. Del Portillo.
• Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus. PLoS neglected tropical diseases 14 4 (2020), J Alonso-Padilla, M Abril, B de Alarcón Noya, Igor C. Almeida, A Angheben, T Araujo Jorge, E Chatelain, M Esteva, J Gascón, M J. Grijalva, F Guhl, A M. Hasslocher-Moreno, M C. López, A Luquetti, O Noya, M J. Pinazo, J M. Ramsey, I Ribeiro, A M. Ruiz, A G. Schijman, S Sosa-Estani, M C. Thomas, F Torrico, M Zrein, A Picado.
• <i>Trypanosoma cruzi</i>-Infected Human Macrophages Shed Proinflammatory Extracellular Vesicles That Enhance Host-Cell Invasion via Toll-Like Receptor 2 Frontiers in Cellular and Infection Microbiology 10 (2020), A Cronemberger-Andrade, P Xander, R P. Soares, N L. Pessoa, M A. Campos, Cameron C. Ellis, Brian Grajeda, Y Ofir-Birin, Igor C. Almeida, N Regev-Rudzki, A C. Torrecilhas.
• A Targeted Mass Spectrometric Analysis Reveals the Presence of a Reduced but Dynamic Sphingolipid Metabolic Pathway in an Ancient Protozoan, Giardia lamblia FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY 9 (2019), Trevor Duarte, Cameron C. Ellis, Grajeda, Brian, I, De Chatterjee, Atasi, Igor C. Almeida, Siddhartha Das.
• A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease. NPJ vaccines 4 (2019), S Portillo, B G. Zepeda, E Iniguez, J J. Olivas, N H. Karimi, O C. Moreira, A F. Marques, Katja Michael, Rosa A. Maldonado-Medina, Igor C. Almeida.
• A prophylactic alpha-Gal-based glycovaccine effectively protects against murine acute Chagas disease NPJ VACCINES 4 (2019), Susana Portillo, Brenda G. Zepeda, Eva Iniguez, Janet J. Olivas, Nasim H. Karimi, Otacilio C. Moreira, Alexandre F. Marques, Katja Michael, Rosa A. Maldonado-Medina, Igor C. Almeida.
• A Targeted Mass Spectrometric Analysis Reveals the Presence of a Reduced but Dynamic Sphingolipid Metabolic Pathway in an Ancient Protozoan, Giardia lamblia FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY 9 (2019), Trevor Duarte, Cameron C. Ellis, Grajeda, Brian, I, De Chatterjee, Atasi, Igor C. Almeida, Siddhartha Das.
• Receptor Heterodimerization and Co-Receptor Engagement in TLR2 Activation Induced by MIC1 and MIC4 from Toxoplasma gondii INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 20 20 (2019), Flavia C. Mendonca-Natividade, Carla D. Lopes, Rafael Ricci-Azevedo, Aline Sardinha-Silva, Camila F. Pinzan, Paiva Alegre-Maller, Ana Claudia, Lilian L. Nohara, Alan B. Carneiro, Ademilson Panunto-Castelo, Igor C. Almeida, Maria C. Roque-Barreira.
• Synthesis of neoglycoproteins as potential biomarkers and vaccines for Chagas disease ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 257 (2019), Elisa G. Carvajal, Susana Portillo, Fikri Avci, Igor C. Almeida, Katja Michael.

• 42. Neoglicoconjugados de alfa-Gal: Novas Perspectivas no Diagnóstico, Tratamento, e Prevenção da Doença de Chagas (2023), Volume Sao Paulo, SP, Brazil, Igor C. Almeida.
• 41. Neoglicoconjugados de alfa-Gal: Novas Perspectivas no Diagnóstico, Tratamento, e Prevenção da Doença de Chagas (2023), Volume Sao Paulo, SP, Brazil, Igor C. Almeida.
• Exploring New Immunosweet Horizons: Trypanosoma cruzi Neoglycoconjugates as Vaccines and Biomarkers for Chagas Disease (2023), Volume Ouro Preto, MG, Brazil, Igor C. Almeida.
• Reversed immunoglycomics for the development of diagnostic biomarkers for Chagas disease (2023), Volume Virtual, Igor C. Almeida.
• Synthesis of an N-acetylglucosamine acceptor as a building block for a Trypanosoma cruzi-derived glycan (2023), Volume Natural Gas Conference Center at UTEP, Ariadne K. Vasquez, Eileni R. Gil, Igor C. Almeida, Katja Michael.
• 38. High Prevalence of Trypanosoma cruzi Infections in Hospitalized Parturient Women in the US-Mexico Border (2023), Volume Galveston, Texas, Igor C. Almeida.
• Reversed immunoglycomics for the development of diagnostic biomarkers for Chagas disease. Dept. of Morphology, Federal (2022), Volume Belo Horizonte, MG, Brazil, Igor C. Almeida.
• Reversed immunoglycomics for the development of diagnostic biomarkers for Chagas disease. (2022), Volume Rio de Janeiro, RJ, Brazil, Igor C. Almeida.
• Reversed immunoglycomics for the development of diagnostic biomarkers for Chagas disease (2022), Volume Belem, PA, Brazil, Igor C. Almeida.
• Reversed immunoglycomics for the development of diagnostic biomarkers for Chagas disease and tegumentary leishmaniasis. (2022), Volume Richland, WA, Igor C. Almeida.
• Glycan-based biomarkers for early assessment of outcomes of Chagas disease chemotherapy. Symposium “Novel biomarkers of disease progression and treatment efficacy in Chagas disease”. (2022), Volume Seattle, WA, Igor C. Almeida.
• Synthesis of novel branched alpha-Gal-containing oligosaccharides derived from Trypanosoma cruzi tGPI-mucins (2022), Volume Edmonton, Alberta, Canada, Elisa G. Carvajal, Uriel Ortega-Rodriguez, Cameron C. Ellis, Igor C. Almeida, Katja Michael.
• TESEO Clinical Trial. Panel: Planned and ongoing clinical studies in Chagas disease. (2022), Volume Hotel Tequendama, Bogotá, Colombia, Igor C. Almeida.
• The Global Burden of Chagas Disease: How Could Basic and Translational Research Alleviate That (2022), Volume El Paso, TX, Igor C. Almeida.
• Glycan-Based Biomarkers for Chagas Disease and Tegumentary Leishmaniasis (2022), Volume Salta, Argentina, Igor C. Almeida.
• Glycan-Based Vaccines and Biomarkers for Chagas Disease (2022), Volume Mendoza, Argentina, Igor C. Almeida.
• Synthesis of branched alpha-Gal-containing glycans derived from Trypanosoma cruzi (2021), Volume Honolulu, HI - virtual, Elisa Garcia Carvajal, Uriel Ortega Rodriguez, Igor C. Almeida, Katja Michael.
• Synthesis of branched alpha-Gal-containing glycans derived from Trypanosoma cruzi (2021), Volume Honolulu, HI - virtual, Elisa Garcia Carvajal, Uriel Ortega Rodriguez, Igor C. Almeida, Katja Michael.
• Specific Recognition of beta-Galactofuranosyl-Containing Glycans by Sera from Chronic Chagas Disease Patients (2021), Volume El Paso, TX, Eileni R. Gil, Alba L. Montoya, Emily L. Heydemann, Igor L. Estevao, Bianca E. Luna, Cameron Ellis, Elisa Garcia Carvajal, Belkisyolé Alarcón de Noya, Oscar Noya, Jorge Diego Marco, Maria Paola Zago, Igor C. Almeida, Katja Michael.
• Specific Recognition of beta-Galactofuranosyl-Containing Glycans by Sera from Chronic Chagas Disease Patients (2021), Volume El Paso, TX, Eileni R. Gil, Alba L. Montoya, Emily L. Heydemann, Igor L. Estevao, Bianca E. Luna, Cameron Ellis, Elisa Garcia Carvajal, Belkisyolé Alarcón de Noya, Oscar Noya, Jorge Diego Marco, Maria Paola Zago, Igor C. Almeida, Katja Michael.
• Glycan-Based Biomarkers and Vaccines for Chagas Disease and Cutaneous Leishmaniasis (2021), Volume Virtual, Igor C. Almeida.
• Reversed Immunoglycomics for Development of Chemotherapeutic Biomarkers and Vaccines in Chagas Disease (2021), Volume Virtual, Igor C. Almeida.
• High resolution mass spectrometric analysis reveals that Giardia cysts are metabolically active and generates membrane lipids with long chain fatty acyl moieties (2021), Volume Virtual , Cameron C. Ellis, Brian I. Grajeda, Breanna C. Pence, Igor C. Almeida, Siddhartha Das.
• Avances en Investigación en Biomarcadores de la Enfermedad de Chagas  (2021), Volume Virtual, Igor C. Almeida.
• Discovery of Glyco-Biomarkers for Old World Cutaneous Leishmaniasis by a Reversed Immunoglycomics Approach (2020), Volume Honolulu, HI - virtual, Alba L. Montoya, Irodiel Vinales, Susana Portillo, Uriel Ortega Rodriguez, Igor L. Estevao, Victoria Austin, Nassim Hosseini, Janet J. Olivas, Sohan R. Jankuru, Roger A. Ashmus, Faustino Torrico, Mary Cruz Torrico, Maria Paola Zago, Jorge Diego Marco, Alvaro Acosta-Serrano, Igor C. Almeida, Katja Michael.
• Discovery of Glyco-Biomarkers for Old World Cutaneous Leishmaniasis by a Reversed Immunoglycomics Approach (2020), Volume Honolulu, HI - virtual, Alba L. Montoya, Irodiel Vinales, Susana Portillo, Uriel Ortega Rodriguez, Igor L. Estevao, Victoria Austin, Nassim Hosseini, Janet J. Olivas, Sohan R. Jankuru, Roger A. Ashmus, Faustino Torrico, Mary Cruz Torrico, Maria Paola Zago, Jorge Diego Marco, Alvaro Acosta-Serrano, Igor C. Almeida, Katja Michael.
• Homenagem ao Prof. Rodolpho Raja Gabaglia Travassos (2020), Volume Virtual, Igor C. Almeida.
• alpha-Gal glycotopes as biomarkers and vaccines for Chagas disease and leishmaniasis (2020), Volume Virtual (Zoom), Igor C. Almeida.
• TESEO Study: New Chemotherapeutic Regimens and Biomarkers for Chagas Disease (2020), Volume Virtual, Igor C. Almeida.
• Professor Luiz Travassos and the alpha-Gal Story in Chagas Disease (2020), Volume Virtual (Zoom), Igor C. Almeida.
• alpha-Gal glycotopes as vaccines and therapeutic biomarkers for Chagas disease (2020), Volume Virtual (Zoom), Igor C. Almeida.
• Characterization of antigenic alpha-Gal-containing extracellular vesicles (EVs) from Trypanosoma cruzi. (2019), Volume Panama City, Panama, Igor C. Almeida.
• alpha-Gal glycotopes as effective glycovaccines and chemotherapy biomarkers in Chagas disease (American trypanosomiasis). (2019), Volume Boston, MA, USA, Igor C. Almeida.
• alpha-Gal glycotopes as effective glycovaccines and chemotherapy biomarkers in Chagas disease (American trypanosomiasis) (2019), Volume Norwich, UK, Igor C. Almeida.
• alpha-Gal glycotopes as effective glycovaccines and chemotherapy biomarkers in Chagas disease (American trypanosomiasis) (2019), Volume Cambridge, UK, Igor C. Almeida.
• alpha-Gal glycotopes as an innovative approach for vaccines and chemotherapy biomarkers in Chagas disease. (2019), Volume Belo Horizonte, MG, Brazil, Igor C. Almeida.
• Early assessment of therapeutic outcomes in experimental and clinical Chagas disease (2019), Volume Hotel Galvez, Galveston, TX, USA, Igor C. Almeida.
• Synthesis of neoglycoproteins as potential diagnostic tools for cutaneous leishmaniasis (2019), Volume Orlando, FL, Alba L. Montoya, V Austin, K S. Subramaniam, S Portillo, E Heydemann, Igor C. Almeida, Alvaro Acosta-Serrano, Katja Michael.

• Targeting cancer with antibodies present in parasitic diseases
• Border Biomedical Research Center - Research Infrastructure Core (RIC)
• Border Biomedical Research Center